These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12413824)

  • 41. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 42. Industrial biocatalysis.
    Zaks A
    Curr Opin Chem Biol; 2001 Apr; 5(2):130-6. PubMed ID: 11282338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
    Beecher N
    IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
    [No Abstract]   [Full Text] [Related]  

  • 44. Algeta and Ablynx collaborate to discover and develop targeted cancer therapies.
    King G
    Future Med Chem; 2013 Feb; 5(2):123. PubMed ID: 23476969
    [No Abstract]   [Full Text] [Related]  

  • 45. Patent protection for protein structure analysis.
    Shimbo I; Nakajima R; Yokoyama S; Sumikura K
    Nat Biotechnol; 2004 Jan; 22(1):109-12. PubMed ID: 14704710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Global "hold-em".
    Cassidy BS
    Geriatr Nurs; 2006; 27(1):21-3. PubMed ID: 16483897
    [No Abstract]   [Full Text] [Related]  

  • 47. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 48. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug buddies.
    Ledford H
    Nature; 2011 Jun; 474(7352):433-4. PubMed ID: 21697923
    [No Abstract]   [Full Text] [Related]  

  • 50. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2003 Dec; 6(12):1195-7. PubMed ID: 14712831
    [No Abstract]   [Full Text] [Related]  

  • 51. New eyes on old drugs.
    Strauss S
    Nat Biotechnol; 2010 Jul; 28(7):633. PubMed ID: 20622811
    [No Abstract]   [Full Text] [Related]  

  • 52. Recent advances in chromosome engineering.
    Kouprina N; Larionov V
    Chromosome Res; 2015 Feb; 23(1):1-5. PubMed ID: 25682170
    [No Abstract]   [Full Text] [Related]  

  • 53. bioLOGIC Europe 2007--Terrapinn's eighth annual conference.
    Mackay J
    IDrugs; 2007 Aug; 10(8):543-8. PubMed ID: 17665328
    [No Abstract]   [Full Text] [Related]  

  • 54. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin in the UK: a setback for gene patents?
    Crespi RS
    Nat Biotechnol; 2005 Mar; 23(3):367-8. PubMed ID: 15765090
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmaceutical industry guide. Strange bedfellows?
    Moore A
    Health Serv J; 2002 Nov; 112(5833):suppl 13-5. PubMed ID: 12478712
    [No Abstract]   [Full Text] [Related]  

  • 57. What shoulder and what art.
    Nat Rev Drug Discov; 2005 Dec; 4(12):943. PubMed ID: 16370069
    [No Abstract]   [Full Text] [Related]  

  • 58. A taste of the future.
    Sheridan C
    Nat Biotechnol; 2004 Oct; 22(10):1203-5. PubMed ID: 15470447
    [No Abstract]   [Full Text] [Related]  

  • 59. Strategic R&D transactions in personalized drug development.
    Makino T; Lim Y; Kodama K
    Drug Discov Today; 2018 Jul; 23(7):1334-1339. PubMed ID: 29574213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.